ArticleGene therapy2001
Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components.
Article in Gene therapy, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 84 citations in OpenAlex.
- The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.Journal of controlled release : official journal of the Controlled Release Society · 2022Article
- Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome.Scientific reports · 2020Article
- Therapeutic siRNA: state of the art.Signal transduction and targeted therapy · 2020Review
- Article
- Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery.Molecular pharmaceutics · 2018Review
- Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.Journal of pharmaceutical sciences · 2017Article
- The involvement of microRNAs in neurodegenerative diseases.Frontiers in cellular neuroscience · 2013Review
- Asymmetric 1-alkyl-2-acyl phosphatidylcholine: a helper lipid for enhanced non-viral gene delivery.International journal of pharmaceutics · 2012Article
- Functional delivery of siRNA in mice using dendriworms.ACS nano · 2009Article
- An efficient liposomal gene delivery vehicle using Sendai F/HN proteins and protamine.Cancer gene therapy · 2008Article
- Gene transfer of the Na+,K+-ATPase beta1 subunit using electroporation increases lung liquid clearance.American journal of respiratory and critical care medicine · 2005Article
- Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection.Journal of molecular medicine (Berlin, Germany) · 2004Review
- Electroporation of the vasculature and the lung.DNA and cell biology · 2003Review
- Article
- Expression of thymidine kinase driven by an endothelial-specific promoter inhibits tumor growth of Lewis lung carcinoma cells in transgenic mice.Gene therapy · 2003Article
- Targeting of Synthetic Gene Delivery Systems.Journal of biomedicine & biotechnology · 2003Article
- In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.Pharmaceutical research · 2002Review
- Robust and prolonged gene expression from injectable polymeric implants.Gene therapy · 2002Article
- Visualization of the transgene distribution according to the administration route allows prediction of the transfection efficacy and validation of the results obtained.Gene therapy · 2002Article
- Delivery systems for pulmonary gene therapy.American journal of respiratory medicine : drugs, devices, and other interventions · 2002Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
We introduce a lung inflation-fixation protocol to examine the distribution and gene transfer efficiency of fluorescently tagged lipoplexes using fluorescence confocal microscopy within thick lung tissue sections. Using this technique, we tested the hypothesis that factors related to lipoplex distribution were the predominant reason that intravenous (i.v.) administration of lipoplex was superior to intratracheal (i.t.) administration for gene transfer in the murine lung. Lipoplex distribution was analyzed using digitized images of overlapping fields, reconstructed to view an entire lung lobe. Intravenously administered lipoplexes were confined to the capillary network and homogenously distributed throughout the lung lobe. In contrast, i.t. administration resulted in regional distribution of lipoplex, concentrated around bronchioles and distal airways. Not all the bronchioles were stained with lipoplex, suggesting that the airway-administered solution became channeled through certain bronchiolar pathways. A fluorescent oligonucleotide was used as a marker for cytoplasmic release of nucleic acids. Quantification of the resulting fluorescent nuclei was used to define the relationship between cytoplasmic release of nucleic acids and gene expression. Endothelial cells were stained after i.v. administration, and epithelial cells were stained after i.t. administration. The delivery of nucleic acids was also more homogeneous with i.v. administration of lipoplex than with i.t. administration. After i.t. administration, it was notable that high concentrations of fluorescent nuclei correlated with low GFP expression. This suggested that toxicity was associated with high local concentrations of cationic lipoplexes. The ratio of GFP-expressing cells to fluorescent nuclei indicated that capillary endothelial cells were more efficient in gene expression per delivery event than were pulmonary epithelial cells. Thus, the greater gene expression efficiency of i.v. administered lipoplexes was due not only to the initial distribution but also to the greater efficiency of the vascular endothelial cells to appropriately traffic and express the foreign gene.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.